“…Therefore, new antitumor drug studies have focused on the design of other metals as well as organic ligands. Metal complexes containing non‐platinum metals (e.g., ruthenium, titanium, gallium, iron, cobalt and gold) were studied in clinical phase or preclinical studies (Achar et al, 2017; Asif et al, 2016; Hackenberg, Lally, et al, 2012; Haque et al, 2018; Nayak & Gaonkar, 2020; Nolan, 2011; Patil, Deally, Gleeson, Hackenberg, et al, 2011; Silver, 2003). Because of the less harmful properties of coinage metals (especially Ag and Au) toward the human body, these metals have been found to be a special key for synthesis of new metallodrugs candidate.…”